Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients - Early Identification of Increased Risk of Infection and Cancer for Individualised Immunosuppression.

NCT04189835 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT04189835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04189835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients - Early Identification of Increased Risk of Infection and Cancer for Individualised Immunosuppression.
Lead sponsor
University of Aarhus
Phase
Observational
Overall status
Completed
Start date
January 3, 2020
Completion date
December 31, 2024
Enrollment
509 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ebv infection, ebv viremia, epstein-barr virus associated lymphoproliferative disorder, post-transplant lymphoproliferative disorder